CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Solarvest Bioenergy Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Solarvest Bioenergy Inc
301 - 1228 Hamilton Street
Phone: (604) 684-3323p:604 684-3323 VANCOUVER, BC  V6B 6L2  Canada Ticker: SVS.HSVS.H
Business Summary
Solarvest BioEnergy Inc. is a Canada-based algae biologics company. The Company’s production platform provides it with a flexible system capable of producing numerous products from Omega 3 fatty acids to human therapeutic proteins. It has developed and patented Omega-3, which is ocean-based (Docosahexaenoic Acid (DHA) & Eicosapentaenoic Acid (EPA)) and organic. The products are produced without chemicals, solvents, and/or heavy processing that degrade the nutritional benefits. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. Its project focuses on cannabinoids, which implements a research and development program to produce cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol (THC). It has also produced Bone Morphogenetic Protein (BMP) in micro algae. Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20247/31/2023Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President MichaelFarley 11/1/2023 11/1/2023
Chief Executive Officer, Director Gerri J.Greenham 1/1/2022 11/9/2005
Interim Chief Financial Officer GerardWatts 7/24/2020 7/24/2020
Independent Director William M.Cheliak 9/22/2009 9/22/2009
Independent Director GregoryDrohan 2/1/2021 2/1/2021

Business Names
Business Name
GCH Capital Partners Inc.
Phyco Hydrogen Inc.
Phycobiologics (Europe) Limited
4 additional Business Names available in full report.

General Information
Outstanding Shares: 60,755,372 (As of 1/31/2024)
Stock Exchange: NEX
Fax Number: (604) 239-0728


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 27, 2024